Merck Announces First Phase Three Studies for PCV-15 (V114) Its Investigational Pneumococcal Disease Vaccine Read more
Sobi Receives Approval from Health Canada for Once-Daily Dosing of Orfadin (nitisinone) for the Treatment of HT-1 Read more
Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford Read more
Discover the future of Pharmaceutical Freeze Drying at SMi’s 6th annual conference, this June Read more